Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2013
11/26/2013US8594940 System and method for analyzing chromosomal states based on gene expression
11/26/2013US8592653 Corn event DAS-59122-7 and methods for detection thereof
11/26/2013US8592571 RNAi modulation of APOB and uses thereof
11/26/2013US8592568 Nucleic acid probes and methods for detecting plasmodium parasites
11/26/2013US8592390 Immunostimulatory method
11/26/2013US8592387 Methods for treating or preventing heart damage with integrin-linked kinase (ILK) compositions
11/26/2013US8592224 Biochip for archiving and laboratory-medical analysis of biological sample material, process for its production, and its use in diagnostic methods
11/26/2013US8592202 Biosensors for detecting macromolecules and other analytes
11/26/2013US8592200 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
11/26/2013US8592183 Apparatus and method for sequencing nucleic acid molecules
11/26/2013US8592182 High throughput nucleic acid sequencing by spacing
11/26/2013US8592176 Methods for forming and using a stratified structure of epithelial cells
11/26/2013US8592175 Nitroreductase enzymatic substrates
11/26/2013US8592174 Peptidase substrates
11/26/2013US8592173 Cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity
11/26/2013US8592172 Bioluminescent assays using cyanobenzothiazole compounds
11/26/2013US8592161 Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
11/26/2013US8592160 Thermal cycler and thermal cycling method
11/26/2013US8592159 Method for detecting presumed IgA nephropathy and method for screening IgA nephropathy patients
11/26/2013US8592158 Detecting multinucleotide repeats
11/26/2013US8592157 Method for separating an analyte from a sample
11/26/2013US8592156 Predicting response to anti-CD20 therapy in DLBCL patients
11/26/2013US8592155 Method of detecting genetic deletions identified with chromosomal abnormalities
11/26/2013US8592154 Methods and apparatus for high speed operation of a chemically-sensitive sensor array
11/26/2013US8592153 Methods for manufacturing high capacitance microwell structures of chemically-sensitive sensors
11/26/2013US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
11/26/2013US8592151 Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
11/26/2013US8592150 Methods and compositions for long fragment read sequencing
11/26/2013US8592149 Methods and compositions for antibody therapy
11/26/2013US8592148 Field-switch sequencing
11/26/2013US8592147 High-content screening for drugs against cancer and age-related diseases
11/26/2013US8592146 Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs
11/26/2013US8592145 Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent
11/26/2013US8592144 Beta-sheet proteins with specific binding properties
11/26/2013US8592143 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
11/26/2013US8592142 Analysis of amino acid copolymer compositions
11/26/2013US8592141 Western blot by incorporating an affinity purification zone
11/26/2013US8592140 Detection of oligosaccharides
11/26/2013US8592139 Test method using cells and test kit therefor
11/26/2013US8591917 Ganglioside based vaccine compositions for subcutaneous administration
11/26/2013US8591904 Asymmetrically branched polymer conjugates and microarray assays
11/26/2013CA2745998C Biomarkers for diagnosing alzheimer's disease
11/26/2013CA2640644C A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses
11/26/2013CA2614118C 4c
11/26/2013CA2612551C Improved extraction methods and assays for feed enzymes
11/26/2013CA2535833C Method and apparatus for assay of electrochemical properties
11/26/2013CA2469472C Endothelial stem cells, populations, methods of isolation and use thereof
11/26/2013CA2457918C Mullerian inhibiting substance levels and ovarian response
11/26/2013CA2450710C Methods for the simultaneous detection of hcv antigens and hcv antibodies
11/26/2013CA2448971C Chimeric flavivirus vectors
11/26/2013CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013CA2417986C Single-labeled oligonucleotide probes
11/26/2013CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/25/2013CA2815869A1 Method of determining the genotype relating to hereditary nasal parakeratosis (hnpk) and nucleic acids usable in said method
11/21/2013WO2013173828A1 Controlling bacterial persister cells with host immune factor
11/21/2013WO2013173821A2 Gtp sensors
11/21/2013WO2013173774A2 Molecular inversion probes
11/21/2013WO2013173644A2 Immunological markers for adjuvant therapy in melanoma
11/21/2013WO2013173525A1 Clinical diagnostic systems
11/21/2013WO2013173509A1 Thermal cycling apparatus and method
11/21/2013WO2013173500A2 Method for predicting recurrence of melanoma using mirna alterations
11/21/2013WO2013173491A1 Primers, assays and methods for detecting burkholderia pseudomallei and burkholderia mallei
11/21/2013WO2013173485A1 Detection of bladder cancers
11/21/2013WO2013173480A1 Detection of bladder cancer recurrence
11/21/2013WO2013173478A1 Screening assay for bladder cancer
11/21/2013WO2013173476A1 Detection of cancer
11/21/2013WO2013173466A1 Methods for inactivation and extraction of acid-fast bacteria for characterization and/or identification using mass spectrometry
11/21/2013WO2013173394A2 Method for increasing accuracy in quantitative detection of polynucleotides
11/21/2013WO2013173312A1 Using modulators of ccr5 for treating cancer
11/21/2013WO2013173031A1 Cell-surface signatures for isolating neurons from cell cultures derived from pluripotent stem cells
11/21/2013WO2013172947A1 Method and system for predicting recurrence and non-recurrence of melanoma using sentinel lymph node biomarkers
11/21/2013WO2013172934A1 Integrin genetic variants and stage-specific tumor recurrence in patients with stage ii and iii colon cancer
11/21/2013WO2013172933A1 Ethnic gene profile of genes involved in angiogenesis may predict regional bevacizumab efficacy difference in gastric cancer
11/21/2013WO2013172932A1 Colon cancer tumor suppressor gene, b-defensin 1, predicts recurrence in patients with stage ii and iii colon cancer
11/21/2013WO2013172922A1 Lmtk3 genotype analysis for use in predicting outcome and therapy selection
11/21/2013WO2013172918A1 Ksr1 gene polymorphism for use in predicting outcome and therapy selection
11/21/2013WO2013172779A2 Method for indicating the presence or non-presence of prostate cancer
11/21/2013WO2013172379A1 Novel antibody and application thereof
11/21/2013WO2013172305A1 Rna detection method and detection kit
11/21/2013WO2013171810A1 Method for obtaining heat-resistant antibody-presenting phage
11/21/2013WO2013171791A1 Method for assessing risk of imprinting disorder
11/21/2013WO2013171753A1 Methods of treating and diagnosing diseases using agents that regulate the alternative splicing pathway
11/21/2013WO2013171673A1 New diagnostic metodology for pancreatic neoplasia
11/21/2013WO2013171515A1 Methods and groups
11/21/2013WO2013171511A1 Methods of quantifying of nucleic acids captured on a solid support.
11/21/2013WO2013171508A1 Method for determining if a subject has an increased likelihood of high grade dysplasia or esophageal adenocarcinoma
11/21/2013WO2013171504A1 Methods to assess the likelihood of dysplasia or esophageal adenocarcinoma
11/21/2013WO2013171489A1 Methods to predict progression of berret ' s esophagus to high grade dysplasia esophageal adenocarcinoma
11/21/2013WO2013171244A1 Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
11/21/2013WO2013171158A1 Methods for the activation of silent genes in a microorganism
11/21/2013WO2013171140A1 Technique combining pcr and loop-mediated isothermal amplification for the detection of nucleic acids
11/21/2013WO2013170994A1 Marker sequences for rheumatoid arthritis
11/21/2013WO2013170744A1 Screening kit for senile macular degeneration
11/21/2013WO2013170429A1 Method, system and computer readable medium for determining base information in predetermined area of fetus genome
11/21/2013WO2013170399A1 Cotton plant event a2-6 and primer and method for use in detection thereof
11/21/2013WO2013170398A1 Cotton plant event a26-5 and primer and method for use in detection thereof
11/21/2013WO2013170314A1 A method of screening for colorectal cancer
11/21/2013WO2013142347A8 Method and system for detection of microbial growth in a specimen container
11/21/2013WO2013132305A8 Size-based analysis of fetal dna fraction in maternal plasma
11/21/2013WO2013127782A3 Use of micro-rnas or genes as markers for the identification, diagnosis and therapy of individual forms of non-ischemic cardiomyopathies or storage diseases of the heart
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 3003